T2*magnetic resonance imaging is more sensitive than histology and serum ferritin for the assessment of iron overload in patients with NAFLD

T2*magnetic resonance imaging is more sensitive than histology and serum ferritin for the assessment of iron overload in patients with NAFLD

Библиографические подробности
Главные авторы:	Pavlides, M, Banerjee, R, Tunnicliffe, E, Wang, L, Ryan, J, Cobbold, J, Neubauer, S, Barnes, E
Формат:	Conference item
Опубликовано:	2014

Схожие документы

Hepatic iron is the major determinant of serum ferritin in NAFLD patients.
по: Ryan, J, и др.
Опубликовано: (2017)

Multi-parametric MRI can diagnose steatohepatitis and cirrhosis in patients with NAFLD
по: Pavlides, M, и др.
Опубликовано: (2014)

Towards the first antibody-free serum biomarker assay for NAFLD
по: Gangadharan, B, и др.
Опубликовано: (2017)

Towards the first antibody-free serum biomarker assay for NAFLD
по: Gangadharan, B, и др.
Опубликовано: (2017)

Platelet and spleen volume criteria exclude more oesophageal varices needing treatment than Baveno VI criteria with 100% sensitivity
по: Levick, C, и др.
Опубликовано: (2018)

A model for hepatic fibrosis: The competing effects of cell loss and iron on shortened Modified Look-Locker inversion recovery T1 (shMOLLI-T1) in the liver
по: Tunnicliffe, E, и др.
Опубликовано: (2016)

FERRITIN IRON-METABOLISM IN FRIEND-LEUKEMIA CELLS
по: Peto, T, и др.
Опубликовано: (1983)

Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias
по: Cappellini, M.D., и др.
Опубликовано: (2010)

Serum ferritin and binding of serum ferritin to concanavalin A as a tumor marker in patients with primary liver cell cancer and chronic liver disease.
по: Chapman, R, и др.
Опубликовано: (1982)

The importance of the fatty acid transporter L-carnitine in non-alcoholic fatty liver disease (NAFLD)
по: Savic, D, и др.
Опубликовано: (2020)

Sex-specific differences in hepatic fat oxidation and synthesis may explain the higher propensity for NAFLD in men
по: Pramfalk, C, и др.
Опубликовано: (2015)

Rapid ferritin iron release using FMN reductase
по: Lai, Mei I., и др.
Опубликовано: (2015)

Novel assay for efficient iron release from ferritin
по: Lim, Wai Feng, и др.
Опубликовано: (2014)

MRE in NAFLD: promising but further validation is required
по: Ryan, J, и др.
Опубликовано: (2018)

Liver iron overload within a UK based population by sex
по: Mckay, A, и др.
Опубликовано: (2017)

Iron overload in mild sideroblastic anaemias.
по: Peto, T, и др.
Опубликовано: (1983)

Serum ferritin is associated with markers of insulin resistance in Japanese men but not in women
по: Ngoc, Minh Pham, и др.
Опубликовано: (2013)

A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health
по: Moolla, A, и др.
Опубликовано: (2019)

Biomarkers of transplantation tolerance: more hopeful than helpful?
по: Cobbold, S, и др.
Опубликовано: (2011)

IRON OVERLOAD IN NON-TRANSFUSED SIDEROBLASTIC ANEMIAS
по: Pippard, M, и др.
Опубликовано: (1982)

High urinary ferritin reflects myoglobin iron evacuation in DMD patients
по: Rouillon, J, и др.
Опубликовано: (2018)

Interobserver variability in histologic evaluation of liver fibrosis using categorical and quantitative scores
по: Pavlides, M, и др.
Опубликовано: (2017)

Quantifying the heterogeneity of liver inflammation and fibrosis in primary sclerosing cholangitis using the interquartile range of iron‐corrected T1 from multi‐parametric MRI
по: Selvaraj, E, и др.
Опубликовано: (2019)

Molecular responses of iron regulatory proteins to iron overload in human liver
по: Neonaki, Maria
Опубликовано: (2006)

Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes.
по: Roy, N, и др.
Опубликовано: (2011)

Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis.
по: Chapman, R, и др.
Опубликовано: (1982)

Microbubbles composition optimisation for ferritin tethering: ensuring activity and structure retention of ferritin
по: Hanna Mariah Binte Mohamed Rizal
Опубликовано: (2024)

Insights into relationships between serum ferritin and liver iron concentration trends during 12 months of iron chelation therapy with deferasirox - a post-hoc analysis from the epic study
по: Porter, J.B., и др.
Опубликовано: (2014)

Porphyria cutanea tarda and beta-thalassaemia minor with iron overload.
по: Chapman, R
Опубликовано: (1980)

COMPREHENSIVE GENETIC TESTING IS REQUIRED FOR PATIENTS WITH UNEXPLAINED IRON OVERLOAD
по: Bignell, P, и др.
Опубликовано: (2013)

Reply to: non-invasive tests and advanced chronic liver disease in NAFLD: two steps forward and one step back?
по: Pavlides, M, и др.
Опубликовано: (2021)

Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload.
по: Sado, D, и др.
Опубликовано: (2014)

Pemeriksaan ferritin, Fe, TIBC dan seturasi transferin serum sebagai tolok ukur defisiensi besi
по: , SETYAWATI, и др.
Опубликовано: (1992)

Pemeriksaan ferritin, Fe, TIBC dan seturasi transferin serum sebagai tolok ukur defisiensi besi
по: , SETYAWATI, и др.
Опубликовано: (1992)

CORRELATION BETWEEN CONTENT HEMOGLOBIN FOR RETICULOCYTE (CHr) AND SERUM FERRITIN IN NEWBORNS AT PKU MUHAMMADIYAH BANTUL YOGYAKARTA
по: , KIRANA KUSUMAWARDHANI, и др.
Опубликовано: (2014)

Serum cystatin C is a more sensitive and more accurate marker of glomerular filtration rate than enzymatic measurements of creatinine in renal transplantation.
по: Christensson, A, и др.
Опубликовано: (2003)

Incorporation of graphene quantum dots, iron, and doxorubicin in/on ferritin nanocages for bimodal imaging and drug delivery
по: Nasrollahi, Fatemeh, и др.
Опубликовано: (2020)

Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload.
по: Townsend, A, и др.
Опубликовано: (2002)

Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload
по: Townsend, A, и др.
Опубликовано: (2002)

Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia
по: Pennell, D.J., и др.
Опубликовано: (2010)